78 related articles for article (PubMed ID: 2674971)
1. Drug binding sites on human alpha-1-acid glycoprotein.
Müller WE
Prog Clin Biol Res; 1989; 300():363-78. PubMed ID: 2674971
[No Abstract] [Full Text] [Related]
2. [Interaction of drugs with alpha 1-acid glycoprotein (orosomucoid)].
Bender KI; Lutsevich AN
Farmakol Toksikol; 1987; 50(5):110-9. PubMed ID: 3319686
[No Abstract] [Full Text] [Related]
3. Drug binding to human alpha-1-acid glycoprotein in health and disease.
Kremer JM; Wilting J; Janssen LH
Pharmacol Rev; 1988 Mar; 40(1):1-47. PubMed ID: 3064105
[No Abstract] [Full Text] [Related]
4. Contribution of the variants of alpha 1-acid glycoprotein to its binding of drugs.
Baumann P; Eap CB
Prog Clin Biol Res; 1989; 300():379-97. PubMed ID: 2674972
[No Abstract] [Full Text] [Related]
5. Binding to alpha 1-acid glycoprotein and relevant apparent volume of distribution.
Bree F; Houin G; Barre J; Riant P; Tillement JP
Prog Clin Biol Res; 1989; 300():321-36. PubMed ID: 2674968
[No Abstract] [Full Text] [Related]
6. Blood binding and tissue transfer of drugs: the influence of alpha 1 acid glycoprotein binding.
Belaiba R; Riant P; Urien S; Brée F; Albengres E; Barré J; Tillement JP
Prog Clin Biol Res; 1989; 300():287-305. PubMed ID: 2674966
[No Abstract] [Full Text] [Related]
7. Human plasma alpha 1-acid glycoprotein--biochemical properties, the amino acid sequence and the structure of the carbohydrate moiety, variants and polymorphism.
Schmid K
Prog Clin Biol Res; 1989; 300():7-22. PubMed ID: 2674975
[No Abstract] [Full Text] [Related]
8. Membrane-induced conformational change of alpha1-acid glycoprotein characterized by vacuum-ultraviolet circular dichroism spectroscopy.
Matsuo K; Namatame H; Taniguchi M; Gekko K
Biochemistry; 2009 Sep; 48(38):9103-11. PubMed ID: 19702310
[TBL] [Abstract][Full Text] [Related]
9. The 1.8-A crystal structure of alpha1-acid glycoprotein (Orosomucoid) solved by UV RIP reveals the broad drug-binding activity of this human plasma lipocalin.
Schönfeld DL; Ravelli RB; Mueller U; Skerra A
J Mol Biol; 2008 Dec; 384(2):393-405. PubMed ID: 18823996
[TBL] [Abstract][Full Text] [Related]
10. Binding site for basic drugs on alpha 1-acid glycoprotein as revealed by chemometric analysis of biochromatographic data.
Kaliszan R; Nasal A; Turowski M
Biomed Chromatogr; 1995; 9(5):211-5. PubMed ID: 8593420
[TBL] [Abstract][Full Text] [Related]
11. Ethnic differences in reactions to drugs and xenobiotics. Other protein variants with pharmacogenetic consequences: albumin and orosomucoid.
Alván G
Prog Clin Biol Res; 1986; 214():345-55. PubMed ID: 3523512
[No Abstract] [Full Text] [Related]
12. Comparison of drug binding capacities of three AAG glycan variants of human origin.
Bree F; Rouzeau JD; Durand G; Gardier A; Tillement JP
Prog Clin Biol Res; 1989; 300():405-8. PubMed ID: 2506553
[No Abstract] [Full Text] [Related]
13. Equilibrium sampling through membrane based on a single hollow fibre for determination of drug-protein binding and free drug concentration in plasma.
Trtić-Petrović T; Liu JF; Jönsson JA
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 826(1-2):169-76. PubMed ID: 16181816
[TBL] [Abstract][Full Text] [Related]
14. Capillary electrophoresis frontal analysis: principles and applications for the study of drug-plasma protein binding.
Østergaard J; Heegaard NH
Electrophoresis; 2003 Sep; 24(17):2903-13. PubMed ID: 12973793
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of certain anti-tuberculosis drugs is affected by binding to alpha-1-acid glycoprotein.
Johnson DA; Smith KD
Biomed Chromatogr; 2006; 20(6-7):551-60. PubMed ID: 16779786
[TBL] [Abstract][Full Text] [Related]
16. Binding of alpha1-acid glycoprotein to membrane results in a unique structural change and ligand release.
Nishi K; Maruyama T; Halsall HB; Handa T; Otagiri M
Biochemistry; 2004 Aug; 43(32):10513-9. PubMed ID: 15301549
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic consequences of altered binding of drugs to alpha 1-acid glycoprotein.
Belpaire FM; Bogaert MG
Prog Clin Biol Res; 1989; 300():337-50. PubMed ID: 2674969
[No Abstract] [Full Text] [Related]
18. Drug binding to alpha 1-acid glycoprotein studied by circular dichroism.
Otagiri M; Yamamichi R; Maruyama T; Imai T; Suenaga A; Imamura Y; Kimachi K
Pharm Res; 1989 Feb; 6(2):156-9. PubMed ID: 2762215
[TBL] [Abstract][Full Text] [Related]
19. Elevated alpha-1-acid glycoprotein reduces the volume of distribution and systemic clearance of saquinavir.
Holladay JW; Dewey MJ; Michniak BB; Wiltshire H; Halberg DL; Weigl P; Liang Z; Halifax K; Lindup WE; Back DJ
Drug Metab Dispos; 2001 Mar; 29(3):299-303. PubMed ID: 11181499
[TBL] [Abstract][Full Text] [Related]
20. [A new two-stage plan for isolating human alpha1-acidic glycoprotein (orosomucoid). Orosomucoid interacts with ethidium bromide].
Trubetskaia OE; Muranova TA; Rezikova OI; Afanas'eva GV; Reznikov KIu
Bioorg Khim; 1994 Dec; 20(12):1297-309. PubMed ID: 7695648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
